top of page

Welcome to Hypermarker

Hypermarker is a research project focused on personalised pharmacometabolomic optimisation of treatment for hypertension. Our aim is to identify the most effective treatment for hypertension based on an individual's unique metabolic profile.

Our Research

We're on a mission to revolutionise hypertension care. Our team leverages cutting-edge tech to personalise pharmacometabolomic solutions, paving the way for healthier lives.

Tonometer with a red heart on a blue background; device for measuring blood pressure

What Inspires Our Work?

For half of hypertension patients, treatment proves ineffective, and the reasons remain elusive. Our mission is to unravel this mystery.

Our Leadership Team

What Makes the Project Special?

"It's one of the first times that we use the metabolome to see whether we can predict the response to treatment."

Diederick Grobbee

News & Updates

Stay in the loop with our Hypermarker news and updates by following us on X (formerly known as Twitter) and connecting with us on LinkedIn.

Our LinkedIn Feed

Our Twitter Feed

Contact Information

 

For more details regarding the Hypermarker project, please reach out to Carl Steinbeisser via email or stay updated by following us on our social media platforms.

​

Email: carl [at] collaborate [dot] eu

EN_FundedbytheEU_RGB_POS.png

This project was funded by the European Union under Grant Agreement number 101095480. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.

  • LinkedIn
  • X
  • Youtube

© 2024 by Collaborate Project Management. 

bottom of page